Daily News 19

Tag: Motley Fool Stock Advisor

  • UnitedHealth Group Stock Surges 39.4% in 6 Months: How High Can It Rise?

    UnitedHealth Group Stock Surges 39.4% in 6 Months: How High Can It Rise?

    UnitedHealth Group (NYSE: UNH) shares have delivered a near 40% gain over the past six months, surging from March 2026 through mid-July before reversing course. The health insurance giant, once a market highflier, benefited from a significant shift in investor sentiment driven by strong earnings and turnaround optimism. However, the recent pullback raises questions about whether the stock will resume its upward trajectory or face continued pressure.

    Strong Earnings and Turnaround Hopes Fuel Mid-2026 Rally

    The extended rally began with a well-received Q1 earnings release. Confidence in UnitedHealth Group’s turnaround remained a top focus and was key to the stock’s surge from $275 to as much as $461.62 between April and July 2026.

    Analysts across Wall Street, including those at Goldman Sachs, BofA, and Morgan Stanley, upgraded the stock. They cited improving utilization trends and management’s commentary that the company’s $3 billion investment in artificial intelligence is already paying off two-to-one.

    Post-Earnings Weakness Reflects Fundamental Concerns

    Since hitting new 52-week highs during the summer, UnitedHealth Group shares have experienced waning enthusiasm. Now trading for just under $400 per share, investors are debating whether a “buy the dip” moment has emerged.

    Worries about fundamentals — not just profit-taking — may be driving the stock’s weak post-earnings price action. Even as favorable utilization trends and cost-cutting measures continue to boost the bottom line, management discussed persistent cost pressures on the Q2 2026 post-earnings conference call. Issues like independent dispute resolutions, as well as increased coverage of GLP-1 and anti-inflammatory drugs, remain key concerns when it comes to rising cost trends.

    Valuation and Long-Term Outlook

    Trading for 18 times estimated 2027 earnings, UnitedHealth appears reasonably priced compared to its historical valuation. If management’s AI-driven turnaround pans out and drives expected earnings growth in the mid-to-high teens over the next three years, recent volatility could seem like a hiccup in hindsight.

    As the company continues to release strong quarterly results, the stock appears to remain a solid long-term buy, even if recent volatility persists in the near-term.

    Analyst Perspective on Portfolio Alternatives

    Before buying stock in UnitedHealth Group, consider that The Motley Fool Stock Advisor analyst team recently identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

    Historical context highlights the potential: when Netflix made this list on December 17, 2004, a $1,000 investment at the time of recommendation would have grown to $421,997. When Nvidia made the list on April 15, 2005, a $1,000 investment would have become $1,413,876.

    Stock Advisor returns as of September 8, 2026. The service’s total average return is 978% — a market-crushing outperformance compared to 213% for the S&P 500.

    Thomas Niel has positions in UnitedHealth Group. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

  • Motley Fool Stock Picks Beat the Market With a 37% Average Return in 2026

    Motley Fool Stock Picks Beat the Market With a 37% Average Return in 2026

    The Motley Fool’s stock recommendations generated an average return of 37% across nine picks released in early 2026, outperforming the broader market by approximately 29 percentage points, according to performance tracking by Wall Street Survivor as of May 2026.

    The investment advisory service has more than 500,000 subscribers and provides two stock recommendations each month through its Stock Advisor program. Its two analyst teams—Hidden Gems, which looks for overlooked quality companies, and Rule Breakers, which targets first movers in emerging sectors—also publish monthly rankings of the service’s top 10 stocks.

    Members receive access to detailed investment research, portfolio tracking tools, and three strategies tailored to different risk tolerances.

    Motley Fool Stock Advisor’s long-term performance

    Motley Fool Stock Advisor reported a 973% total return as of August 27, 2026, compared with a 213% gain for the S&P 500 over the same 24-year period since the service launched in February 2002. The 760-percentage-point difference reflects the service’s long-term approach of identifying strong companies early and holding them through multiple market cycles.

    Several individual recommendations illustrate the potential impact of that strategy. Amazon, recommended on September 6, 2002, delivered a reported return of 34,003%. Netflix, selected on December 17, 2004, returned 44,246%, while Nvidia, recommended on April 15, 2005, gained 130,663%. Disney, selected on June 7, 2002, returned 6,250%.

    How the Motley Fool’s analyst teams work

    Co-founders David Gardner and Tom Gardner lead the service’s respective analyst teams. Tom Gardner’s team focuses on financially sound companies in beaten-down industries that may be positioned for a recovery. The team also considers the quality of a company’s financials and whether its management is aligned with shareholders.

    David Gardner’s team searches for businesses positioned to benefit from long-term secular trends. Its strategy emphasizes identifying companies early, particularly those with sustainable competitive advantages.

    Motley Fool Stock Advisor cost and features

    Stock Advisor costs $199 per year and includes a 30-day money-back guarantee. Subscribers receive two new stock picks each month, a curated list of the service’s top 10 stocks, detailed research, portfolio tracking, and access to an online investor community.

    The service’s record of outperforming the broader market over more than two decades has attracted individual investors looking for an alternative to passive index investing and short-term active trading.

    Past performance does not guarantee future results. However, the service’s emphasis on fundamental analysis, long-term growth companies, and patient buy-and-hold investing may appeal to investors prepared to hold positions for at least five years and accept the risks of investing in individual stocks.